Return to search

PE HUB Second Opinion

Pfizer decides not to split; instead the pharmaceutical giant will focus on M&A and developing new drugs.

As they head into their first presidential debate, new polls show Clinton and Trump in a dead heat.

Germany’s Lanxess to buy U.S. chemical firm Chemtura for $2.7 billion.

Disney is in talks with bankers about a possible Twitter acquisition.

Zynga hires a game veteran as its chief marketing officer.

Lands’ End CEO Federica Marchionni steps down.

Rising gun violence fuels crime surges in many cities, says FBI.

On the heels of the company’s fake accounts scandal, fired Wells Fargo workers are fighting back with a lawsuit.

MTV is bringing back TRL — to get young people registered to vote.

Photo: A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. Reuters/Francois Lenoir